Molecular targeted therapy for thyroid cancer in Japan: a call to reduce the backlog.
Yamashita
Shunichi
S
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D018265:Carcinoma, Papillary, Follicular / Q000188:drug therapy* / Q000235:genetics; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards; D016503:Drug Delivery Systems; D006288:Health Planning Organizations / Q000639:trends; D006297:Health Services Accessibility / Q000639:trends; D006801:Humans; D007564:Japan; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000235:genetics; D013997:Time Factors
D000970:Antineoplastic Agents